Healthcare Realty Trust (NYSE:HR) Stock, Quote.Headers.trade-ideas

Healthcare Realty Trust

Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.

Movers

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

EXPI

RDFN

Top 3 Real Estate Stocks That May Implode In Q2

Business,Handshake

Equities

Large Cap

REIT

Real Estate

KKR forms JV with Healthcare Realty for 12 medical properties worth $382.5M, with potential value of $1B with KKR&#39;s $600M commitment.

Why KKR Shares Are Trading Higher Today

Dividends

Price Target

Analyst Ratings

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a  high dividend payout. 

Wall Street&#39;s Most Accurate Analysts Say Hold These 3 Real Estate Stocks With Over 4% Dividend Yields

Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust Inc

HEAR ATLAST HOLDINGS INC by Hear AtLast Holdings, Inc.

Hear AtLast Holdings Inc

Hera SpA

H&R Block Inc

HARBOR BANKSHARES CORP by Harbor Bankshares Corporation

Harbor Bankshares Corp

HARBOR DIVERSIFIED INC by Harbor Diversified, Inc.

Harbor Diversified Inc

HERSHEY CREAMERY CO by Hershey Creamery Co.

Hershey Creamery Co

Hurricane Energy PLC

Huarui International New Material Ltd

Here Media Inc

Stans Energy Corp

Harfang Exploration Inc

HERITAGE NOLA BANCORP INC by Heritage Nola Bancorp Inc

Heritage NOLA Bancorp Inc

HARGREAVES LANSDOWN ORD by Hargreaves Lansdown PLC

Hargreaves Lansdown PLC

Hargreaves Lansdown PLC ADR

HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc.

Harvard Apparatus Regenerative Technology Inc

Herc Holdings Inc

Horiba Ltd

REVOLUTION CO LTD by REVOLUTION CO LTD.

Hormel Foods Corp

High Roller Technologies, Inc

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Holdings Inc

Hydro One Ltd

HRnetGroup Ltd

HIROSE ELECTRIC UNSP/ADR by Hirose Electric

Hirose Electric Co Ltd

HIROGIN HOLDINGS INC by Hirogin Holdings Inc.

Hirogin Holdings Inc

Harrow Inc

Harrow, Inc. - 8.625% senior notes due 2026

Harrow, Inc. - 11.875% Senior Notes due 2027

HAIER SMART HOME CO LTD by HAIER SMART HOME CO LTD.

Haier Smart Home Co Ltd

HORRISON RESOURCES INC by Horrison Resources Inc.

Horrison Resources Inc

HARVEST OIL & GAS CORP by Harvest Oil & Gas Corp.

Harvest Oil & Gas Corp

HIRERIGHT HLDGS CORP COM

Heritage Insurance Holdings, Inc. Common Stock

Heritage Insurance Holdings Inc

Tema GLP-1, Obesity & Cardiometabolic ETF

Heart Tronics Inc

Heron Therapeutics Inc

H&R Real Estate Investment Trust Stapled Units Cons of 1 H&R REIT Ut ' 1 H&R Finance Trust Ut

H&R Real Estate Investment Trust

Harvia PLC

Hanryu Holdings Inc

HORIZON CONST DEV LTD by HORIZON CONSTRUCTION DEVELOPMENT LTD.

Horizon Construction Development Ltd

HORIZON MINERALS LTD by HORIZON MINERALS LTD.

Horizon Minerals Ltd

Horizon Technology Finance Corporation - Common Stock

Horizon Technology Finance Corp

<p>In the preceding three months, 5 analysts have released ratings for Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $16.4, a high estimate of $17.00, and a low estimate of $16.00. Marking an increase of 6.49%, the current average surpasses the previous average price target of $15.40. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720551702_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The perception of Healthcare Realty Trust by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Healthcare Realty Trust. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Healthcare Realty Trust compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Healthcare Realty Trust's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Healthcare Realty Trust analyst ratings.</strong></a></p>
<h2>About Healthcare Realty Trust</h2>
<p>Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.</p>
<h3>Key Indicators: Healthcare Realty Trust's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Healthcare Realty Trust faced challenges, resulting in a decline of approximately <strong>-1.84%</strong> in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Healthcare Realty Trust's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-95.11%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-4.7%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-2.49%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Healthcare Realty Trust's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.84</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


5 Analysts Assess Healthcare Realty Trust: What You Need To Know

<p>Scotiabank  analyst Nicholas Yulico   maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Sector Perform and raises the price target from $16 to $17.</p>


Scotiabank Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $17

<p><i>Multi-tenant new leases signed totaling 432,000 square feet&nbsp;</i><br /><br /><i>1H 2024 multi-tenant occupancy gain of 183,000 square feet, above guidance range&nbsp;</i><br /><br /><i>Steward Health has paid substantially all rent for June and July&nbsp;</i><br /><br /><i>Greater than $1 billion in completed or planned asset sales and JV transactions&nbsp;</i><br /><br /><i>$286 million in shares repurchased to date</i></p>
<p>NASHVILLE, Tenn., July 08, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) today provided a second quarter update on its operational and capital allocation momentum.</p>
<p>OPERATIONAL MOMENTUM<br /><br />In the second quarter, new signed leases totaled 432,000 square feet, the fourth consecutive quarter above 400,000. Multi-tenant absorption in the second quarter was 122,000 square feet. Combined with the first quarter, multi-tenant absorption for the first half of the year was 183,000 square feet, which was above the guidance range of 90,000 to 140,000 square feet provided in the Company's Multi-tenant Occupancy and NOI Bridge. Over the last three quarters, multi-tenant occupancy has increased 371,000 square feet, representing approximately 110 basis points of positive absorption.</p>


Guidance

Healthcare Realty Trust Provides Q2 Business Update On Operational And Capital Allocation Momentum; Expect This Progress To Lead To Improved Dividend Coverage And Accelerated FFO Growth

Healthcare Realty Trust Announced It Has Generated About $400M Of Proceeds From Joint Venture (JV) And Asset Sale Transactions Year-to-date

<p>Wells Fargo  analyst Joseph Feldman   maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Equal-Weight and raises the price target from $16 to $17.</p>


Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Raises Price Target to $17

<p>$227 million of proceeds from contributions to KKR JV<br /><br />&nbsp;</p>
<p>Repurchased shares totaling over $175 million</p>
<p>NASHVILLE, Tenn., June 03, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) announced in early May that it had entered into a strategic joint venture with KKR ("KKR JV") to own and invest in quality medical outpatient buildings. To date, the Company has contributed 10 properties to the KKR JV that have generated $227 million of proceeds. The Company expects to contribute additional properties to the KKR JV that will bring total proceeds in excess of $300 million. Beyond the initial property contributions, KKR has committed up to an additional $600 million of capital to increase the potential value of the JV to $1 billion. Healthcare Realty will retain a 20% interest and manage the JV, as well as continue to oversee day-to-day operations and leasing of the properties.</p>


Contracts

Healthcare Realty Trust Provides Update On Capital Allocation Progress, Has Contributed 10 Properties To The KKR JV That Have Generated $227M Of Proceeds; Has Additional Transactions Under Contract And Letters Of Intent That Are Expected To Generate Further Proceeds Of More Than $300M By Early August

<p>In the last three months, 5 analysts have published ratings on Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $16.0, a high estimate of $17.00, and a low estimate of $15.00. Highlighting a 2.44% decrease, the current average has fallen from the previous average price target of $16.40. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1717092034_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The standing of Healthcare Realty Trust among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Connor Siversky</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Michael Mueller</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Healthcare Realty Trust. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Healthcare Realty Trust compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Healthcare Realty Trust's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Healthcare Realty Trust analyst ratings.</strong></a></p>
<h2>Delving into Healthcare Realty Trust's Background</h2>
<p>Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.</p>
<h3>Healthcare Realty Trust's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Healthcare Realty Trust's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately <strong>-1.84%</strong> in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Healthcare Realty Trust's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-95.11%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Healthcare Realty Trust's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-4.7%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Healthcare Realty Trust's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-2.49%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Healthcare Realty Trust's debt-to-equity ratio is below the industry average. With a ratio of <b>0.84</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Unveiling 5 Analyst Insights On Healthcare Realty Trust

<p>Wells Fargo  analyst James Feldman   maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Equal-Weight and raises the price target from $15 to $16.</p>


Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Raises Price Target to $16

<p>Scotiabank  analyst Nicholas Yulico   maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Sector Perform and raises the price target from $15 to $16.</p>


Scotiabank Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $16

<p>As of May 15, 2024, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. </p>
<p>Here's the latest list of major overbought players in this sector.</p>
<h3 class="wp-block-heading"><strong>Redfin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>)</strong></h3>
<ul>
<li>On May 13, Susquehanna analyst Shyam Patil maintained Redfin with a Neutral and raised the price target from $7 to $8. The company's stock gained around 14% over the past five days and has a <a href="https://www.benzinga.com/quote/RDFN">52-week high of $17.68</a>.</li>
<li><strong>RSI Value:</strong> 75.65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>RDFN Price Action:</strong> Shares of Redfin fell 1.3% to close at $7.90 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>)</strong></h3>
<ul>
<li>On May 7, Healthcare Realty Trust posted better-than-expected quarterly FFO. The company's stock gained around 17% over the past month and <a href="https://www.benzinga.com/quote/HR">has a 52-week high</a> of $20.25.</li>
<li><strong>RSI Value:</strong> 78.75</li>
<li><strong>HR Price Action:</strong> Shares of Healthcare Realty Trust rose 1.6% to close at $16.27 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading"><strong>eXp World Holdings, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPI#NASDAQ">EXPI</a>)</h3>
<ul>
<li>On May 1, eXp World Holdings reported better-than-expected first-quarter financial results. &#8220;During the first quarter, our agents closed over $37 billion of transactions, a 12% year-over-year increase, underscoring eXp&#8217;s unparalleled scale in the cloud brokerage market we pioneered,&#8221; said Glenn Sanford, eXp World Holdings Founder, Chairman and CEO. &#8220;We continue to provide our agents with the industry&#8217;s best platform for growth and the resources they need to navigate today&#8217;s dynamic real estate market.&#8221; The company's stock gained around 33% over the past month and has a <a href="https://www.benzinga.com/quote/EXPI">52-week high</a> of $25.39.</li>
<li><strong>RSI Value:</strong> 70.31</li>
<li><strong>EXPI Price Action:</strong> Shares of eXp World rose 2.9% to close at $12.93 on Tuesday.</li>
</ul>
<p>Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38835382/investor-optimism-improves-ahead-of-cpi-report-nasdaq-settles-at-record-high">Investor Optimism Improves Ahead Of CPI Report, Nasdaq Settles At Record High</a></p>


<p>Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Healthcare Realty Trust and provided 12-month price targets. The average target is $15.6, accompanied by a high estimate of $17.00 and a low estimate of $15.00. A decline of 13.33% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715184056_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The standing of Healthcare Realty Trust among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Connor Siversky</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Michael Mueller</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Stephen Manaker</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$15.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Healthcare Realty Trust. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Healthcare Realty Trust compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Healthcare Realty Trust's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Healthcare Realty Trust's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Healthcare Realty Trust analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Healthcare Realty Trust</h2>
<p>Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.</p>
<h3>Financial Insights: Healthcare Realty Trust</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Healthcare Realty Trust's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately <strong>-2.25%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Healthcare Realty Trust's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-12.68%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Healthcare Realty Trust's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-0.61%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Healthcare Realty Trust's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-0.33%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Healthcare Realty Trust's debt-to-equity ratio is below the industry average. With a ratio of <b>0.78</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Cracking The Code: Understanding Analyst Reviews For Healthcare Realty Trust

<p>Wedbush  analyst Richard Anderson   maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Neutral and raises the price target from $15 to $16.</p>


Wedbush Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $16

<p>Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) affirms FY2024 FFO guidance from $1.52-1.58 to $1.52-1.58 vs $1.56 analyst estimate..</p>


Healthcare Realty Trust Affirms FY2024 FFO Guidance $1.52-1.58 vs $1.56 Est

<p>Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) is looking for Q2 FFO of $0.38-0.39 vs $0.39 analyst estimate..</p>


Healthcare Realty Trust Sees Q2 FFO $0.38-0.39 vs $0.39 Est

<p>Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) reported quarterly FFO of $0.39 per share which beat the analyst consensus estimate of $0.38 by 2.63 percent. This is a 2.5 percent decrease over FFO of $0.40 per share from the same period last year. The company reported quarterly sales of $326.81 million which missed the analyst consensus estimate of $326.89 million by 0.03 percent. This is a 1.84 percent decrease over sales of $332.93 million the same period last year.</p>


Earnings

Healthcare Realty Trust Q1 Adj. FFO $0.39 Beats $0.38 Estimate, Sales $326.81M Miss $326.89M Estimate

<p><strong>KKR &amp; Co. Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) and <strong>Healthcare Realty Trust Incorporated</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) have inked a strategic joint venture (JV) relationship to jointly own and invest in <a href="https://www.benzinga.com//node/38637050">quality medical outpatient buildings.</a></p>
<p>The JV constitutes 12 properties that are medical outpatient buildings, having a total of 762,399 square feet (98% occupied), across seven top markets located predominantly on or adjacent to leading hospital campuses. </p>
<p>As per the terms, Healthcare Realty will contribute 12 of its existing properties to seed the JV at a value of $382.5 million, representing a cap rate of approximately 6.6%. </p>
<p>The contribution of the properties is expected to occur throughout May and June, upon satisfaction of customary closing conditions.</p>
<p>The Healthcare REIT expects to receive around $300 million in proceeds for the contribution. The company will also partner with KKR to explore additional acquisitions, including the potential contribution of more Healthcare Realty properties to the JV.</p>
<p>KKR will make an equity contribution of 80%, while Healthcare Realty will retain a 20% interest and will manage the JV along with overseeing day-to-day operations and leasing of the properties.&nbsp;</p>
<p>KKR has also committed up to $600 million to the JV to increase the potential value of the JV to more than $1 billion.</p>
<p>Also, in another release today, KKR announced&nbsp;the signing of definitive agreements&nbsp;to acquire Healthium Medtech Ltd. from an&nbsp;<a target="_blank" href="https://www.benzinga.com//node/38638078" rel="noreferrer noopener">affiliate of Funds advised&nbsp;by Apax Partners LLP</a>.</p>
<p>As of the quarter-end, KKR's cash and&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/05/38554722/whats-going-on-with-kkr-shares-wednesday" rel="noreferrer noopener">investments stood at&nbsp;$14.6 billion</a>.</p>
<p>Investors can gain exposure to the stock via&nbsp;<strong>Northern Lights Fund Trust IV FMC Excelsior Focus Equity ETF&nbsp;</strong>(FMCX)&nbsp;and&nbsp;<strong>EA Series Trust WHITEWOLF Publicly Listed Private Equity ETF&nbsp;</strong>(LBO).</p>
<p><strong>Price Action</strong>: KKR shares are up 2.82% at $97.69, while HR is up 1.31% at $15.08 at the last check Monday.</p>
<p><em>Photo via Shutterstock</em></p>


<p>Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) today announced that it has entered into a strategic joint venture (JV) relationship with KKR to jointly own and invest in quality medical outpatient buildings. Healthcare Realty expects to receive approximately&nbsp;$300 million&nbsp;in proceeds for the contribution of a seed portfolio to the JV and will partner with KKR to explore additional acquisitions, including the potential contribution of more Healthcare Realty properties to the JV.</p>
<p>Under the terms of the agreement, Healthcare Realty will contribute 12 of its existing properties to seed the JV at a value of&nbsp;$382.5 million, representing a cap rate of approximately&nbsp;6.6%. KKR will make an equity contribution to the JV equal to&nbsp;80%&nbsp;of the value of the properties. Healthcare Realty will retain a&nbsp;20%&nbsp;interest and will manage the JV, as well as continue to oversee day-to-day operations and leasing of the properties. KKR has also committed up to&nbsp;$600 million&nbsp;to the JV to pursue additional acquisitions or contributions of high-quality stabilized assets that are a match for its long-term capital base.</p>


Healthcare Realty and KKR Team Up to Invest $600M in Quality Medical Real Estate

<p>Wells Fargo  analyst Connor Siversky   maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Equal-Weight and lowers the price target from $18 to $15.</p>


Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Lowers Price Target to $15

<p>During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"><em> high dividend payout. </em></a></p>
<p>Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie"><em> by analyst accuracy </em></a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.</p>
<h3><strong>PotlatchDeltic Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pch#NASDAQ">PCH</a>)</h3>
<ul>
<li><strong>Dividend Yield:</strong> 4.07%</li>
<li><strong>RBC Capital</strong> analyst Matthew McKellar reiterated a Sector Perform rating with a price target of $48 on Jan. 31, 2024. This analyst has an accuracy rate of 64%.</li>
<li><strong>Truist Securities</strong> analyst Michael Roxland maintained a Hold rating and cut the price target from $51 to $49 on Jan. 31, 2024. This analyst has an accuracy rate of 67%.</li>
<li><strong>Recent News:</strong> On Jan. 29, PotlatchDeltic posted better-than-expected quarterly sales.</li>
</ul>
<h3><strong>Healthcare Realty Trust Incorporated</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hr#NYSE">HR</a>)</h3>
<ul>
<li><strong>Dividend Yield:</strong> 9.45%</li>
<li><strong>Wedbush</strong> analyst Richard Anderson downgraded the stock from Outperform to Neutral and cut the price target from $19 to $15 on Feb. 20, 2024. This analyst has an accuracy rate of 62%.</li>
<li><strong>Citigroup</strong> analyst Michael Griffin maintained a Neutral rating and slashed the price target from $19 to $17 on Aug. 22, 2023. This analyst has an accuracy rate of 74%.</li>
<li><strong>Recent News:</strong> On Feb. 16, Healthcare Realty Trust posted a decline in sales for the fourth quarter.</li>
</ul>
<h3><strong>National Health Investors, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nhi#NYSE">NHI</a>)</h3>
<ul>
<li><strong>Dividend Yield:</strong> 5.94%</li>
<li><strong>Wells Fargo</strong> analyst Todd Stender maintained an Equal-Weight rating and raised the price target from $54 to $55 on Nov. 27, 2023. This analyst has an accuracy rate of 68%.</li>
<li><strong>Jefferies</strong> analyst Joe Dickstein initiated coverage on the stock with a Hold rating and a price target of $52 on Sept. 20, 2023. This analyst has an accuracy rate of 64%.</li>
<li><strong>Recent News:</strong> On Feb. 20, National Health Investors posted better-than-expected quarterly results.</li>
</ul>
<p>&nbsp;</p>
<p>Read More: <a href="https://www.benzinga.com/news/earnings/24/03/37811812/core-main-caleres-and-3-stocks-to-watch-heading-into-tuesday"><em> Core &amp; Main, Caleres And 3 Stocks To Watch Heading Into Tuesday</em></a></p>
<p>&nbsp;</p>


Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks With Over 4% Dividend Yields

<p>By the close of today, March 14, 2024, <b>Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>)</b> will issue a dividend payout of $0.31 per share, resulting in an annualized dividend yield of 7.87%. This payout is exclusively for shareholders who held the stock before the ex-dividend date on February 23, 2024.</p>
<h3>Healthcare Realty Trust Recent Dividend Payouts</h3>
<style>
        table {
            width: 100%;
            border-collapse: collapse;
            font-family: Arial, sans-serif;
            font-size: 14px;
        }

        th, td {
            padding: 8px;
            text-align: left;
        }

        th {
            background-color: #293a5a;
            color: #fff;
            text-align: left;
        }

        tr:nth-child(even) {
            background-color: #f2f4f8;
        }

        tr:hover {
            background-color: #e1e4ea;
        }

        td:nth-child(3), td:nth-child(5) {
            text-align: left;
        }

        .dividend-amount {
            font-weight: bold;
            color: #0d6efd;
        }

        .dividend-frequency {
            font-size: 12px;
            color: #6c757d;
        }
    </style><table>
<thead>
<tr>
<th><strong>Ex-Date</strong></th>
<th style="text-align: right;"><strong>Payments per year</strong></th>
<th><strong>Dividend</strong></th>
<th><strong>Yield</strong></th>
<th><strong>Announced</strong></th>
<th><strong>Record</strong></th>
<th><strong>Payable</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>2024-02-23</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>7.87%</td>
<td>2024-02-13</td>
<td>2024-02-26</td>
<td>2024-03-14</td>
</tr>
<tr>
<td>2023-11-13</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>8.78%</td>
<td>2023-10-30</td>
<td>2023-11-14</td>
<td>2023-11-30</td>
</tr>
<tr>
<td>2023-08-14</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>6.35%</td>
<td>2023-08-01</td>
<td>2023-08-15</td>
<td>2023-08-30</td>
</tr>
<tr>
<td>2023-05-15</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>6.31%</td>
<td>2023-05-02</td>
<td>2023-05-16</td>
<td>2023-06-02</td>
</tr>
<tr>
<td>2023-03-06</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>6.15%</td>
<td>2023-02-24</td>
<td>2023-03-07</td>
<td>2023-03-21</td>
</tr>
<tr>
<td>2022-11-14</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>6.1%</td>
<td>2022-11-02</td>
<td>2022-11-15</td>
<td>2022-11-30</td>
</tr>
<tr>
<td>2022-08-12</td>
<td style="text-align: right;">4</td>
<td>$0.11</td>
<td>1.7%</td>
<td>2022-08-03</td>
<td>2022-08-15</td>
<td>2022-08-30</td>
</tr>
<tr>
<td>2022-05-13</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>4.34%</td>
<td>2022-05-03</td>
<td>2022-05-16</td>
<td>2022-05-27</td>
</tr>
<tr>
<td>2022-02-25</td>
<td style="text-align: right;">4</td>
<td>$0.31</td>
<td>4.0%</td>
<td>2022-02-16</td>
<td>2022-02-28</td>
<td>2022-03-15</td>
</tr>
<tr>
<td>2021-11-12</td>
<td style="text-align: right;">4</td>
<td>$0.3</td>
<td>3.63%</td>
<td>2021-11-02</td>
<td>2021-11-15</td>
<td>2021-11-30</td>
</tr>
<tr>
<td>2021-08-13</td>
<td style="text-align: right;">4</td>
<td>$0.3</td>
<td>3.83%</td>
<td>2021-08-03</td>
<td>2021-08-16</td>
<td>2021-08-31</td>
</tr>
<tr>
<td>2021-05-14</td>
<td style="text-align: right;">4</td>
<td>$0.3</td>
<td>3.75%</td>
<td>2021-05-04</td>
<td>2021-05-17</td>
<td>2021-05-28</td>
</tr>
</tbody>
</table>
<p>When comparing Healthcare Realty Trust's dividend yield against its industry peers, the company sits comfortably in the middle, with its peer <b>Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>)</b> having the highest annualized dividend yield at 19.91%.</p>
<h3>Analyzing Healthcare Realty Trust Financial Health</h3>
<p>Companies that pay out steady cash dividends are attractive to income-seeking investors, and companies that are financially healthy tend to maintain their dividend payout schedule. For this reason, investors can find it insightful to see if a company has been increasing or decreasing their dividend payout schedule and if their earnings are growing. </p>
<h3>YoY Growth in Dividend Per Share</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1710428740_0.png" alt="dividend chart graph" /></p>
<p>From 2020 to 2023, the company's dividend per share showed a positive trend, increasing steadily from $1.20 in 2020 to $1.24 in 2023. This demonstrates the company's commitment to rewarding shareholders by consistently raising dividends.</p>
<h3>YoY Earnings Growth For Healthcare Realty Trust</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1710428740_1.png" alt="earning chart graph" /></p>
<p>The earnings chart highlights a decrease in Healthcare Realty Trust's earnings per share, declining from $1.65 in 2020 to $1.60 in 2023. This decline in earnings raises a red flag for income-seeking investors, as it suggests a potential decrease in the company's ability to generate cash for dividend payouts. It is essential to closely examine the factors behind this decrease and assess the long-term impact on dividend sustainability.</p>
<h3>Recap</h3>
<p>This article delves into the recent dividend payout of Healthcare Realty Trust and its implications for shareholders. Presently, the company is distributing a dividend of $0.31 per share, leading to an annualized dividend yield of 7.87%.</p>
<p>When comparing Healthcare Realty Trust's dividend yield against its industry peers, the company sits comfortably in the middle, with its peer Medical Properties Trust having the highest annualized dividend yield at 19.91%.</p>
<p>Given that Healthcare Realty Trust has experienced an increase in dividend per share from 2020 to 2023 along with a decrease in earnings per share, it could indicate that the company is prioritizing dividend distribution to shareholders despite challenges in earnings growth.</p>
<p>It is essential for investors to closely track the company's performance in the coming quarters to remain updated regarding any alterations in financials or dividend disbursements.</p>
<p>\To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.  </p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Healthcare Realty Trust Adapts to Economic Shifts to Support Investor Confidence

Why Now Is The Time To Load Up On REITs, And 2 'Strong Buys'

A Fragile Facade

Healthcare Realty Trust to reserve ~$3M of Steward Health-related unpaid rent in Q2

Dividend Opportunity Alert: EPR Properties And Healthcare Realty

Healthcare Realty: Strong Leasing Velocity, Hefty Dispositions, And A Bold Capital Strategy

REITs Rip As Rates Retreat

Michael Gorman, an analyst from BTIG, maintained the Buy rating on Healthcare Realty Trust (HR – Research Report). The associated price target is $...

Buy Rating Affirmed for Healthcare Realty Trust Amid Positive Performance and Strategic Growth Initiatives

KeyBanc analyst Austin Wurschmidt maintained a Hold rating on Healthcare Realty Trust (HR – Research Report) today. The company's shares closed yes...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Healthcare Realty Trust

Healthcare Realty Trust (HR) Forecast

Healthcare Realty Trust (NYSE:HR) Stock, Quote.Headers.trade-ideas